NorthView Acquisition Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Jack Stover
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 3.1yrs |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | 2.4yrs |
Recent management updates
Recent updates
CEO
Jack Stover (70 yo)
3.1yrs
Tenure
Mr. Jack E. Stover, CPA, served as Director at PharmaCyte Biotech, Inc. since 2022 until November 01, 2022 and he has been Chief Executive Officer, Co-Founder and Director of NorthView Acquisition Corporat...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 3.1yrs | no data | no data | |
| Co-Founder | 3.1yrs | no data | no data | |
| Independent Director | 2.4yrs | no data | no data | |
| Independent Chairman | 2.4yrs | no data | no data | |
| Independent Director | 2.4yrs | no data | no data |
2.4yrs
Average Tenure
62yo
Average Age
Experienced Board: NVAC's board of directors are not considered experienced ( 2.4 years average tenure), which suggests a new board.